Biologicals, 2015-2019

  • Voorlopige cijfers Zvw
  Vergoeding (1=1.000)
  2015 2016 2017 2018 2019
  ATC-code  
  D11AH05 Dupilumab . . . 7.061 15.084
  L04AA18 Everolimus . . 16 75 62
  L04AA23 Natalizumab 16.037 16.914 17.719 19.404 19.296
  L04AA24 Abatacept 15.069 15.887 17.254 17.447 18.215
  L04AA25 Eculizumab 31.651 35.336 35.611 34.727 36.907
  L04AA26 Belimumab 71 165 180 700 1.146
  L04AA28 Belatacept . 343 567 757 912
  L04AA29 Tofacitinib . . 530 3.508 9.373
  L04AA32 Apremilast 102 2.108 2.886 3.801 4.410
  L04AA33 Vedolizumab 8.561 15.397 21.616 29.372 36.136
  L04AA34 Alemtuzumab 1.957 4.509 4.347 4.603 2.829
  L04AA36 Ocrelizumab . . . 7.832 25.794
  L04AA37 Baricitinib . . 690 4.070 6.190
* L04AB01 Etanercept 148.397 142.940 125.781 103.021 65.955
* L04AB02 Infliximab 154.584 139.574 107.759 102.350 88.270
* L04AB04 Adalimumab 220.014 215.955 215.598 217.018 88.129
* L04AB05 Certolizumab pegol 8.695 9.937 11.177 12.356 12.572
* L04AB06 Golimumab 23.478 23.305 20.538 20.209 19.312
  L04AC Interleukineremmers . . . . 274
* L04AC03 Anakinra 2.285 2.208 2.759 2.844 3.298
* L04AC05 Ustekinumab 34.684 32.579 41.413 51.450 60.302
  L04AC07 Tocilizumab 24.252 24.505 25.287 27.300 27.697
  L04AC08 Canakinumab 2.203 3.604 7.408 15.061 17.277
  L04AC10 Secukinumab 1.226 9.526 16.444 19.542 22.807
  L04AC11 Siltuximab 77 19 63 64 9
  L04AC12 Brodalumab . . 26 445 814
  L04AC13 Ixekizumab . 113 2.072 4.804 7.399
  L04AC14 Sarilumab . . 11 296 1.581
  L04AC16 Guselkumab . . . 1.305 5.781
  Totaal   693.343 694.924 677.753 711.420 597.833